Controlling Ice Nucleation During the Freezing Step of Lyophilization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Controlling Ice Nucleation During the Freezing Step of Lyophilization
Lyophilization technologies for controlled nucleation.


Pharmaceutical Technology
Volume 37, Issue 5, pp. 36-40

References

1. ABB website, "Freeze Drying in the Pharmaceutical Industry," http://www.abb.com/, accessed Apr. 9, 2013.

2. R. Bursac, R. Sever, and B. Hunek, BioProcess Int. 7 (9) 66-72 (2009).

3. K Scoffin and L Ciccolini, BioPharm Int. 26 (3) 46-51 (2013).

4. A. Hottot, S. Vessot, and J. Andrieu, Drying Technology 22 (8) 2009-2021 (2004).

5. M.L. Roy and M.J. Pikal, J Parenter. Sci. Technol. 43, 60–66 (1989).

6. J.A. Searles, J. F. Carpenter, and T.W. Randolph, J Pharm. Sci. 90, 860–871 (2001).

7. A.K. Konstantinidis et al, J Pharm. Sci. 100 (8) 3453-70 (2011).

8. P. Startzel, M. Gieseler, and H. Gieseler, "Rational Freeze-Drying Cycle Optimization Using Two Innovative Technologies: SMART Freeze-Dryer and ControLyo Nucleation On-Demand," presentation at the Controlled Release Society Germany Local Chapter Meeting (Wuerzburg, Mar., 2012).

9. G.A. Sacha and R. Sever, "Controlled Nucleation in Lyophilization: The Effects on Lyophilization Time and Physical Appearance of Lyophilized Pharmaceutical Excipients," presentation at the CPPR Freeze Drying of Pharmaceuticals & Biologicals Conference (Breckenridge, CO, Aug., 2012).

10. G.B. Strambini and E. Gabellieri, Biophys. J 70 (2) 971-976. (1996).

11. A. Millqvist-Fureby, M. Malmsten, and B. Bergenstahl, Int. J Pharm. 191 (2) 103-114 (1999).

12. B.S. Chang, B.S. Kendrick, and J.F. Carpenter, J Pharm. Sci. 85 (12) 1325–1330 (1996).

13. S. Jiang and S.L. Nail, Eur. J Pharm. Biopharm. 45 (3) 249-257 (1998).

14. M. Pikal, "Advances in Controlled Ice Nucleation," presentation at the PEP Talk Conference (Palm Springs, CA, Jan., 2013).

15. P. Chakravarty et al, BioPharm Int. 25 (1) 33-38 (2012).

16. P. Thomas, PharmaManufacturing website, "Controlled Ice Nucleation Moves into Manufacturing," http://www.pharmamanufacturing.com/, accessed Apr. 9, 2013.

17. J. Brower, "Ice Fog Induced Nucleation: A Case Study," presentation at the First Annual Lyo Summit: Lyophilization Conference (Garmisch-Partenkirchen, Germany, Oct., 2012).

18. R. Sever et al, "ControLyo Nucleation On-Demand Technology: New Case Studies and Manufacturing Scale Implementation," presentation at the PEP Talk Conference (SanDiego, Jan., 2012).

19. M. Shon and B. Uchil, "Scale-Up of Controlled Nucleation to a Production Environment," presentation at the PEP Talk Conference (Palm Springs, CA, Jan., 2013).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here